[Ip-health] MSF Statement on the Establishment of a Consultative EWG on Research and Development: Financing and Coordination at 63rd WHA

Katy.ATHERSUCH at geneva.msf.org Katy.ATHERSUCH at geneva.msf.org
Fri May 21 10:04:19 PDT 2010


   Following the adoption of the resolution to establish a Consultative Expert
   Working Group on Research and Development: Financing and Coordination at
   63rd WHA, MSF has made the following statement: "We are very pleased.  This
   is  very  good  resolution  The member states have recognised that the
   limitations  of  the EWG report - in terms of process transparency and
   substance - and have put in place measures to address these.  Crucially they
   have addressed the fact that the EWG did not look at proposals to stimulate
   research and development against the principle of de-linking the cost of
   research from the price of the product.  This is explicitly recognised as a
   key  principle and they have restored the exploration and promotion of
   innovative proposals that allow de-linking, such as the proposals from
   Bolivia Barbados, Bangladesh and Suriname, including a prize fund for a
   much-needed TB point-of-care diagnostic.
   The resolution also says that in the long-term, proposals that allow for
   sustainable change should be looked at.  One of these is the R&D treaty - in
   2009, the World Health Assembly said discussions on an R&D treaty would not
   be continued.  Today, the WHA has mandated member states to do just this."
   Michelle Childs, Director Policy Advocacy MSF Access Campaign



More information about the Ip-health mailing list